Post-Traumatic Stress Disorder Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Antidepressants
1.2.3 Anti-Anxiety Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder Treatment Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder Treatment Market Perspective (2018-2032)
2.2 Post-Traumatic Stress Disorder Treatment Growth Trends by Region
2.2.1 Post-Traumatic Stress Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Post-Traumatic Stress Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Region (2023-2032)
2.3 Post-Traumatic Stress Disorder Treatment Market Dynamics
2.3.1 Post-Traumatic Stress Disorder Treatment Industry Trends
2.3.2 Post-Traumatic Stress Disorder Treatment Market Drivers
2.3.3 Post-Traumatic Stress Disorder Treatment Market Challenges
2.3.4 Post-Traumatic Stress Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder Treatment Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder Treatment Players by Revenue (2018-2023)
3.1.2 Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Post-Traumatic Stress Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder Treatment Revenue
3.4 Global Post-Traumatic Stress Disorder Treatment Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder Treatment Revenue in 2022
3.5 Post-Traumatic Stress Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder Treatment Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder Treatment Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Type (2023-2032)
5 Post-Traumatic Stress Disorder Treatment Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Post-Traumatic Stress Disorder Treatment Market Size (2018-2032)
6.2 North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023)
6.3 North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder Treatment Market Size (2018-2032)
7.2 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023)
7.3 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size (2018-2032)
8.2 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023)
8.3 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder Treatment Market Size (2018-2032)
9.2 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023)
9.3 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size (2018-2032)
10.2 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023)
10.3 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Detail
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.1.5 Pfizer, Inc. Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Detail
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Treatment Introduction
11.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Otsuka Pharmaceutical Co., Ltd
11.3.1 Otsuka Pharmaceutical Co., Ltd Company Detail
11.3.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Treatment Introduction
11.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.3.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Post-Traumatic Stress Disorder Treatment Introduction
11.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.4.5 Novartis AG Recent Development
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Company Detail
11.5.2 AstraZeneca Plc Business Overview
11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Treatment Introduction
11.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.5.5 AstraZeneca Plc Recent Development
11.6 Azevan Pharmaceuticals, Inc.
11.6.1 Azevan Pharmaceuticals, Inc. Company Detail
11.6.2 Azevan Pharmaceuticals, Inc. Business Overview
11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.6.5 Azevan Pharmaceuticals, Inc. Recent Development
11.7 Bionomics Ltd.
11.7.1 Bionomics Ltd. Company Detail
11.7.2 Bionomics Ltd. Business Overview
11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Treatment Introduction
11.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.7.5 Bionomics Ltd. Recent Development
11.8 Tonix Pharmaceuticals Holding Corp.
11.8.1 Tonix Pharmaceuticals Holding Corp. Company Detail
11.8.2 Tonix Pharmaceuticals Holding Corp. Business Overview
11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Treatment Introduction
11.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.8.5 Tonix Pharmaceuticals Holding Corp. Recent Development
11.9 Apotex, Inc.
11.9.1 Apotex, Inc. Company Detail
11.9.2 Apotex, Inc. Business Overview
11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
11.9.5 Apotex, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Antidepressants
Table 3. Key Players of Anti-Anxiety Drugs
Table 4. Key Players of Others
Table 5. Global Post-Traumatic Stress Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 6. Global Post-Traumatic Stress Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 7. Global Post-Traumatic Stress Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Post-Traumatic Stress Disorder Treatment Market Share by Region (2018-2023)
Table 9. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 10. Global Post-Traumatic Stress Disorder Treatment Market Share by Region (2023-2032)
Table 11. Post-Traumatic Stress Disorder Treatment Market Trends
Table 12. Post-Traumatic Stress Disorder Treatment Market Drivers
Table 13. Post-Traumatic Stress Disorder Treatment Market Challenges
Table 14. Post-Traumatic Stress Disorder Treatment Market Restraints
Table 15. Global Post-Traumatic Stress Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Post-Traumatic Stress Disorder Treatment Market Share by Players (2018-2023)
Table 17. Global Top Post-Traumatic Stress Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Treatment as of 2022)
Table 18. Ranking of Global Top Post-Traumatic Stress Disorder Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Post-Traumatic Stress Disorder Treatment Product Solution and Service
Table 22. Date of Enter into Post-Traumatic Stress Disorder Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Post-Traumatic Stress Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 27. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Type (2023-2032)
Table 28. Global Post-Traumatic Stress Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 31. Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Application (2023-2032)
Table 32. North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032) & (US$ Million)
Table 34. Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032) & (US$ Million)
Table 36. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2023-2032) & (US$ Million)
Table 38. Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032) & (US$ Million)
Table 40. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2023-2032) & (US$ Million)
Table 42. Pfizer, Inc. Company Detail
Table 43. Pfizer, Inc. Business Overview
Table 44. Pfizer, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 45. Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 46. Pfizer, Inc. Recent Development
Table 47. GlaxoSmithKline plc Company Detail
Table 48. GlaxoSmithKline plc Business Overview
Table 49. GlaxoSmithKline plc Post-Traumatic Stress Disorder Treatment Product
Table 50. GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 51. GlaxoSmithKline plc Recent Development
Table 52. Otsuka Pharmaceutical Co., Ltd Company Detail
Table 53. Otsuka Pharmaceutical Co., Ltd Business Overview
Table 54. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Treatment Product
Table 55. Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 56. Otsuka Pharmaceutical Co., Ltd Recent Development
Table 57. Novartis AG Company Detail
Table 58. Novartis AG Business Overview
Table 59. Novartis AG Post-Traumatic Stress Disorder Treatment Product
Table 60. Novartis AG Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 61. Novartis AG Recent Development
Table 62. AstraZeneca Plc Company Detail
Table 63. AstraZeneca Plc Business Overview
Table 64. AstraZeneca Plc Post-Traumatic Stress Disorder Treatment Product
Table 65. AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 66. AstraZeneca Plc Recent Development
Table 67. Azevan Pharmaceuticals, Inc. Company Detail
Table 68. Azevan Pharmaceuticals, Inc. Business Overview
Table 69. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 70. Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 71. Azevan Pharmaceuticals, Inc. Recent Development
Table 72. Bionomics Ltd. Company Detail
Table 73. Bionomics Ltd. Business Overview
Table 74. Bionomics Ltd. Post-Traumatic Stress Disorder Treatment Product
Table 75. Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 76. Bionomics Ltd. Recent Development
Table 77. Tonix Pharmaceuticals Holding Corp. Company Detail
Table 78. Tonix Pharmaceuticals Holding Corp. Business Overview
Table 79. Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Treatment Product
Table 80. Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 81. Tonix Pharmaceuticals Holding Corp. Recent Development
Table 82. Apotex, Inc. Company Detail
Table 83. Apotex, Inc. Business Overview
Table 84. Apotex, Inc. Post-Traumatic Stress Disorder Treatment Product
Table 85. Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2018-2023) & (US$ Million)
Table 86. Apotex, Inc. Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Traumatic Stress Disorder Treatment Market Share by Type: 2022 VS 2032
Figure 2. Antidepressants Features
Figure 3. Anti-Anxiety Drugs Features
Figure 4. Others Features
Figure 5. Global Post-Traumatic Stress Disorder Treatment Market Share by Application in 2022 & 2032
Figure 6. Hospitals Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Post-Traumatic Stress Disorder Treatment Report Years Considered
Figure 10. Global Post-Traumatic Stress Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 11. Global Post-Traumatic Stress Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 12. Global Post-Traumatic Stress Disorder Treatment Market Share by Region: 2022 VS 2032
Figure 13. Global Post-Traumatic Stress Disorder Treatment Market Share by Players in 2022
Figure 14. Global Top Post-Traumatic Stress Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder Treatment Revenue in 2022
Figure 16. North America Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 17. North America Post-Traumatic Stress Disorder Treatment Market Share by Country (2018-2032)
Figure 18. United States Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. Canada Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Europe Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Europe Post-Traumatic Stress Disorder Treatment Market Share by Country (2018-2032)
Figure 22. Germany Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. France Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. U.K. Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. Italy Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Russia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Nordic Countries Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Share by Region (2018-2032)
Figure 30. China Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Japan Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. South Korea Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. Southeast Asia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. India Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Australia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Latin America Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Latin America Post-Traumatic Stress Disorder Treatment Market Share by Country (2018-2032)
Figure 38. Mexico Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Brazil Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Share by Country (2018-2032)
Figure 42. Turkey Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Saudi Arabia Post-Traumatic Stress Disorder Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 45. GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 46. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 47. Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 48. AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 49. Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 50. Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 51. Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 52. Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed